Chris Kim
Chief Executive Officer CelleMEDY
Seminars
Thursday 11th June 2026
T-Sphaera: A Next-Generation Biopharmaceutical Development Platform Enabling Advanced Multispecific Therapeutics
4:00 pm
- Explore how T-Sphaera is a proprietary development platform designed to enable the rational engineering of next-generation multispecific biologics with enhanced stability, manufacturability, and functional precision
- Discuss how the platform supports flexible modular design, allowing optimization of target engagement, conditional activation, and therapeutic index across diverse oncology applications
- Examine how T-Sphaera-derived candidates were shown to improve tumor selectivity and translational predictability, supporting advancement toward clinical development
Thursday 11th June 2026
Chair’s Closing Remarks
4:30 pm
